Tanshinol ameliorates CCl₄-induced liver fibrosis in rats through the regulation of Nrf2/HO-1 and NF-κB/IκBα signaling pathway

References

• OakleyFMesoMIredaleJPInhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosisGastroenterology2005128110812015633128
   PubMed Web of Science ®Google Scholar
• DongSChenQLSongYNMechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysisJ Toxicol Sci201641456157227452039
   PubMed Web of Science ®Google Scholar
• LiJPGaoYChuSFNrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol-and CCl4-induced hepatic fibrosisActa Pharmacol Sin20143581031104424976156
   PubMed Web of Science ®Google Scholar
• SánchezvalleVCháveztapiaNCUribeMMéndezsánchezNRole of oxidative stress and molecular changes in liver fibrosis: a reviewCurr Med Chem201219284850486022709007
   PubMed Web of Science ®Google Scholar
• ZhuWFungPCThe roles played by crucial free radicals like lipid free radicals, nitric oxide, and enzymes NOS and NADPH in CCl(4)-induced acute liver injury of miceFree Radic Biol Med200029987088011063912
   PubMed Web of Science ®Google Scholar
• ChenSZouLLiLWuTThe protective effect of glycyrrhetinic acid on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2PLoS One201381e5366223341968
   PubMed Web of Science ®Google Scholar
• GuLTaoXXuYDioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathwayToxicol Appl Pharmacol2016292192926747300
   PubMed Web of Science ®Google Scholar
• CaiZLouQWangFN-acetylcysteine protects against liver injure induced by carbon tetrachloride via activation of the Nrf2/HO-1 pathwayInt J Clin Exp Pathol20148786558662
   Web of Science ®Google Scholar
• LiuMWuQChenPA boswellic acid-containing extract ameliorates schistosomiasis liver granuloma and fibrosis through regulating NF-κB signaling in micePLoS One201496e10012924941000
   PubMed Web of Science ®Google Scholar
• LueddeTSchwabeRFNF-κB in the liver–linking injury, fibrosis and hepatocellular carcinomaNat Rev Gastroenterol Hepatol20118210811821293511
   PubMed Web of Science ®Google Scholar
• MannJOakleyFAkiboyeFElsharkawyAThorneAWMannDARegulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesisCell Death Differ200714227528516763620
   PubMed Web of Science ®Google Scholar
• KongDZhangFWeiDPaeonol inhibits hepatic fibrogenesis via disrupting nuclear factor-κB pathway in activated stellate cells: in vivo and in vitro studiesJ Gastroenterol Hepatol20132871223123323425217
   PubMed Web of Science ®Google Scholar
• YuCQiDLianWLiQZLiHJFanHYEffects of danshensu on platelet aggregation and thrombosis: in vivo arteriovenous shunt and venous thrombosis models in ratsPLoS One2014911e11012425375124
   PubMed Web of Science ®Google Scholar
• HungMA novel Danshensu derivative confers cardioprotection via PI3K/Akt and Nrf2 pathwaysInt J Cardiol201316821349135923290949
   PubMed Web of Science ®Google Scholar
• FanGYuJFordjourAPDanshensu alleviates cardiac ischaemia/reperfusion injury by inhibiting autophagy and apoptosis via activation of mTOR signallingJ Cell Mol Med201620101908191927385290
   PubMed Web of Science ®Google Scholar
• ZhangLJChenLLuYDanshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasionEur J Pharmacol20106432–319520120621088
   PubMed Web of Science ®Google Scholar
• HuaLFanSDuanLRPaeonol and danshensu combination attenuates apoptosis in myocardial infarcted rats by inhibiting oxidative stress: Roles of Nrf2/HO-1 and PI3K/Akt pathwaySci Rep201662369327021411
   PubMed Web of Science ®Google Scholar
• GuoCYinYDuanJNeuroprotective effect and underlying mechanism of sodium danshensu [3-(3,4-dihydroxyphenyl) lactic acid from Radix and Rhizoma Salviae miltiorrhizae=Danshen] against cerebral ischemia and reperfusion injury in ratsPhytomedicine201522228328925765834
   PubMed Web of Science ®Google Scholar
• PengRWangSWangRWangYYWuYYuanYFAntifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathwaysDiscov Med201723125819428371611
   PubMed Web of Science ®Google Scholar
• WangRZhangHWangYJSongFXYuanYFInhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-κB/IκBα, p38 MAPK, and Bcl-2/Bax signalingInt Immunopharmacol20174712613328391159
   PubMed Web of Science ®Google Scholar
• NiYHHuoLJLiTTAntioxidant axis Nrf2-keap1-ARE in inhibition of alcoholic liver fibrosis by IL-22World J Gastroenterol201723112002201128373766
   PubMed Web of Science ®Google Scholar
• PellicoroAIredaleJPReply to Elastin-based molecular MRI of liver fibrosisHepatology20135841518151923424101
   PubMed Web of Science ®Google Scholar
• AttaHMReversibility and heritability of liver fibrosis: implications for research and therapyWorld J Gastroenterol201521175138514825954087
   PubMed Web of Science ®Google Scholar
• EomYWShimKYBaikSKMesenchymal stem cell therapy for liver fibrosisKorean J Intern Med201530558058926354051
   PubMed Web of Science ®Google Scholar
• ZouLChenSLiLWuTThe protective effect of hyperoside on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2Exp Toxicol Pathol201769745146028434817
   PubMedGoogle Scholar
• TangNZhangYLiuZFuTLiangQAiXCorrelation analysis between four serum biomarkers of liver fibrosis and liver function in infants with cholestasisBiomed Rep20165110711227347413
   PubMed Web of Science ®Google Scholar
• BansalRNagórniewiczBPrakashJClinical advancements in the targeted therapies against liver fibrosisMediators Inflamm201620163116
   Web of Science ®Google Scholar
• YangNShiJJWuFPCaffeic acid phenethyl ester up-regulates antioxidant levels in hepatic stellate cell line T6 via an Nrf2-mediated mitogen activated protein kinases pathwayWorld J Gastroenterol20172371203121428275300
   PubMed Web of Science ®Google Scholar
• RezaHMTabassumNSagorMAAngiotensin-converting enzyme inhibitor prevents oxidative stress, inflammation, and fibrosis in carbon tetrachloride-treated rat liverToxicol Mech Methods2016261465326862777
   PubMed Web of Science ®Google Scholar
• IlavenilSKaleeswaranBRavikumarSProtective effects of lycorine against carbon tetrachloride induced hepatotoxicity in Swiss albino miceFundamClinPharmacol2012263393401
   Google Scholar
• EdeasMAttafDMailfertASNasuMJoubetRMaillard reaction, mitochondria and oxidative stress: potential role of antioxidantsPatholBiol (Paris)2010583220225
   PubMedGoogle Scholar
• KimJChaYNSurhYJA protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disordersMutat Res20106901–2122319799917
   PubMed Web of Science ®Google Scholar
• ShinSMYangJHKiSHRole of the Nrf2-ARE pathway in liver diseasesOxid Med Cell Longev20132013676325723766860
   PubMed Web of Science ®Google Scholar
• ShuMHuangDDHungZAHuXRZhangSInhibition of MAPK and NF-κB signaling pathways alleviate carbon tetrachloride (CCl4)-induced liver fibrosis in Toll-like receptor 5 (TLR5) deficiency miceBiochem Biophys Res Commun2016471123323926845355
   PubMed Web of Science ®Google Scholar
• WangRYuXYGuoZYWangYJWuYYuanYFInhibitory effects of salvianolic acid B on CCl 4-induced hepatic fibrosis through regulating NF-κB/IκBα signalingJ Ethnopharmacol2012144359259823041223
   PubMed Web of Science ®Google Scholar
• SasakiYIwaiKRoles of the NF-κB pathway in B-lymphocyte biologyCurr Top Microbiol Immunol2015393177209
   Web of Science ®Google Scholar
• HerpersBWinkSFredrikssonLActivation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicityArch Toxicol20169051163117926026609
   PubMed Web of Science ®Google Scholar
• KöhlerUABöhmFRolfsFNF-κB/RelA and Nrf2 cooperate to maintain hepatocyte integrity and to prevent development of hepatocellular adenomaJ Hepatol20166419410226348541
   PubMed Web of Science ®Google Scholar